0001209191-20-020659.txt : 20200323
0001209191-20-020659.hdr.sgml : 20200323
20200323164431
ACCESSION NUMBER: 0001209191-20-020659
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200319
FILED AS OF DATE: 20200323
DATE AS OF CHANGE: 20200323
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bright Rex
CENTRAL INDEX KEY: 0001327501
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38356
FILM NUMBER: 20735377
MAIL ADDRESS:
STREET 1: 5641 LAKE VISTA DRIVE
CITY: BONSALL
STATE: CA
ZIP: 92003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Menlo Therapeutics Inc.
CENTRAL INDEX KEY: 0001566044
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 453757789
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 CARDINAL WAY, 2ND FLOOR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-486-1416
MAIL ADDRESS:
STREET 1: 200 CARDINAL WAY, 2ND FLOOR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER COMPANY:
FORMER CONFORMED NAME: Menlo Therapeutics, Inc.
DATE OF NAME CHANGE: 20170728
FORMER COMPANY:
FORMER CONFORMED NAME: Tigercat Pharma, Inc.
DATE OF NAME CHANGE: 20130104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-19
0
0001566044
Menlo Therapeutics Inc.
MNLO
0001327501
Bright Rex
200 CARDINAL WAY, 2ND FLOOR
REDWOOD CITY
CA
94063
1
0
0
0
Stock Option
2.67
2020-03-19
4
A
0
45000
0.00
A
2030-03-19
Common Stock
45000
45000
D
The option will vest and become exercisable as to 1/3rd of the shares subject to the option on each annual anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
/s/ Mutya Harsch as attorney-in-fact for Rex Bright
2020-03-23